Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morag Park

Showing results (81-90 of 195) with videos related to

Pageof 20
Sort By:
Breast Cancer Research : BCR|August 22, 2012
Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypesFrançois Pepin, Nicholas Bertos, Julie Laferrière, et al.
Cell Reports|December 19, 2019
LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and InvasionEmily S Bell, Paula Pinto Coelho, Colin D H Ratcliffe, et al.
Stem Cell Reports|March 14, 2017
Lineage Specification from Prostate Progenitor Cells Requires Gata3-Dependent Mitotic Spindle OrientationMaxwell E R Shafer, Alana H T Nguyen, Mathieu Tremblay, et al.
Biology Open|September 14, 2014
Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast CancersCharles Vadnais, Peiman Shooshtarizadeh, Charles V Rajadurai, et al.
Plos One|December 3, 2010
In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcomeSimen Myhre, Hayat Mohammed, Trine Tramm, et al.
Breast Cancer Research : BCR|October 24, 2006
Gene expression signatures of morphologically normal breast tissue identify basal-like tumorsGreg Finak, Svetlana Sadekova, Francois Pepin, et al.
Molecular Biology of the Cell|November 19, 2004
HGF converts ErbB2/Neu epithelial morphogenesis to cell invasionHanane Khoury, Monica A Naujokas, Dongmei Zuo, et al.
Anti-Cancer Drugs|June 8, 2018
DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapyCynthia Bernier, Ahmed Soliman, Michel Gravel, et al.
Cellular and Molecular Life Sciences : CMLS|March 6, 2022
Met-HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cellsYaakov E Stern, Abdulhameed Al-Ghabkari, Anie Monast, et al.
Journal of the National Cancer Institute|October 31, 2019
Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment ApproachYacine Bareche, Laurence Buisseret, Tina Gruosso, et al.
Pageof 20

Showing results (81-90 of 195) with videos related to

Sort By:
Pageof 20
Breast Cancer Research : BCR|August 22, 2012
Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypesFrançois Pepin, Nicholas Bertos, Julie Laferrière, et al.
Cell Reports|December 19, 2019
LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and InvasionEmily S Bell, Paula Pinto Coelho, Colin D H Ratcliffe, et al.
Stem Cell Reports|March 14, 2017
Lineage Specification from Prostate Progenitor Cells Requires Gata3-Dependent Mitotic Spindle OrientationMaxwell E R Shafer, Alana H T Nguyen, Mathieu Tremblay, et al.
Biology Open|September 14, 2014
Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast CancersCharles Vadnais, Peiman Shooshtarizadeh, Charles V Rajadurai, et al.
Plos One|December 3, 2010
In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcomeSimen Myhre, Hayat Mohammed, Trine Tramm, et al.
Breast Cancer Research : BCR|October 24, 2006
Gene expression signatures of morphologically normal breast tissue identify basal-like tumorsGreg Finak, Svetlana Sadekova, Francois Pepin, et al.
Molecular Biology of the Cell|November 19, 2004
HGF converts ErbB2/Neu epithelial morphogenesis to cell invasionHanane Khoury, Monica A Naujokas, Dongmei Zuo, et al.
Anti-Cancer Drugs|June 8, 2018
DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapyCynthia Bernier, Ahmed Soliman, Michel Gravel, et al.
Cellular and Molecular Life Sciences : CMLS|March 6, 2022
Met-HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cellsYaakov E Stern, Abdulhameed Al-Ghabkari, Anie Monast, et al.
Journal of the National Cancer Institute|October 31, 2019
Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment ApproachYacine Bareche, Laurence Buisseret, Tina Gruosso, et al.
Pageof 20